Amneal Pharmaceuticals Q4 Adj. EPS $0.21 Beats $0.18 Estimate, Sales $814.319M Beat $807.895M Estimate

Amneal Pharmaceuticals (NASDAQ:AMRX) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.18 by 13.51 percent. This is a 75 percent increase over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $814.319 million which beat the analyst consensus estimate of $807.895 million by 0.80 percent. This is a 11.47 percent increase over sales of $730.518 million the same period last year.